Additional studies by the samegroup indicated that PPAR-γ expression was reduced in PBMCs from MS patientsrelative to healthy donors, which correlated with decreased anti-inflammatoryeffects of pioglitazone on patient-derived PBMCs [77]. This evidence concerns the gene PPARG and myeloid sarcoma.